Literature DB >> 6619580

Clostridium difficile toxin A in infants.

J M Libby, S T Donta, T D Wilkins.   

Abstract

C difficile produces two toxins, each of which is cytotoxic and lethal to animals [1]. Whether one or both of the toxins is responsible for pseudomembranous colitis in humans is unknown. C difficile is rarely found in the intestinal tracts of healthy adults, and then only in relatively low numbers. The same numbers of C difficile found in adults with pseudomembranous colitis may be present in infants with no obvious adverse effects [3]. The primary cytotoxin of C difficile, toxin B, may also be found in these infants, but the presence of toxin A, which causes intestinal fluid accumulation and mucosal necrosis in hamsters, has not been demonstrated [3]. However, an ELISA developed in our laboratory has been used to detect toxin A in fecal specimens from adults with pseudomembranous colitis [1]. Using this assay, we attempted to determine whether this toxin might be found in hospitalized infants with no obvious gastrointestinal distress. Ten of the 21 infants tested had toxin A in their feces. No infant had toxin A in the absence of toxin B. This is not surprising, because both toxins are produced in about the same ratio in vitro by all strains of C difficile we have tested [1]. In general, those specimens with high titers of toxin B had correspondingly high concentrations of toxin A. The infant with the highest titers of both toxin A and B was the eight-month-old infant with a clinical diagnosis of antibiotic-associated colitis. The other nine infants with toxin A had no enteric symptoms.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6619580     DOI: 10.1093/infdis/148.3.606

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Clostridium difficile infection of the gut.

Authors:  A P Dodson; S P Borriello
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

Review 2.  Diversity, stability and resilience of the human gut microbiota.

Authors:  Catherine A Lozupone; Jesse I Stombaugh; Jeffrey I Gordon; Janet K Jansson; Rob Knight
Journal:  Nature       Date:  2012-09-13       Impact factor: 49.962

3.  Detection of Clostridium difficile enterotoxin in neonates by latex agglutination.

Authors:  H Ushijima; T Shinozaki; R Fujii
Journal:  Arch Dis Child       Date:  1985-03       Impact factor: 3.791

Review 4.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

5.  Heterogeneity of Clostridium difficile isolates from infants.

Authors:  A Collignon; L Ticchi; C Depitre; J Gaudelus; M Delmée; G Corthier
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

6.  Effect of various diets on toxin production by two strains of Clostridium difficile in gnotobiotic mice.

Authors:  S Mahe; G Corthier; F Dubos
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

7.  Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection.

Authors:  M Warny; J P Vaerman; V Avesani; M Delmée
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

8.  Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc.

Authors:  H C Krivan; G F Clark; D F Smith; T D Wilkins
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

9.  Role of volatile fatty acids in colonization resistance to Clostridium difficile.

Authors:  R D Rolfe
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

Review 10.  The impact of Clostridium difficile on paediatric surgical practice: a systematic review.

Authors:  D Mc Laughlin; F Friedmacher; P Puri
Journal:  Pediatr Surg Int       Date:  2014-07-10       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.